Dementia in Canada: what the projections tell us

Dementia in Canada: What the projections tell us   June 2026 Canada is facing a rapidly growing dementia crisis. Right now, an estimated 772,000 Canadians are living with dementia. Every day, more than 414 people in Canada receive a new diagnosis, and according to the Alzheimer Society of Canada’s Landmark Study the scale of what lies…

Read More

The Alzheimer’s drug pipeline has never looked more promising

The Alzheimer’s drug pipeline has never looked more promising   May 19 2026 A landmark new analysis shows more drugs, more trials, and more targets than ever before. For decades, the field moved slowly, marked by failed trials, limited options, and a disease that seemed to resist every attempt to slow it. But a sweeping…

Read More

From Lab to Life Event at The Djavad Mowafaghian Centre for Brain Health

From Lab to Life Event: Inside the science driving leading-edge dementia research May 7, 2026   An afternoon inside the future of Alzheimer’s research On May 7, CLEAR Foundation welcomed supporters and researchers to the Djavad Mowafaghian Centre for Brain Health (DMCBH) for From Lab to Life, an immersive event showcasing some of British Columbia’s…

Read More

Advancing Alzheimer’s & Parkinson’s Research in BC | New Team Award

Announcing groundbreaking research for Alzheimer’s and Parkinson’s in British Columbia January 27, 2026   CLEAR Foundation is proud to collaborate with partners across BC to advance innovative research in Alzheimer’s and Parkinson’s diseases. The Advancing Groundbreaking Research in Alzheimer’s and Parkinson’s Diseases – Team Award is a new, BC-led funding opportunity designed to support bold…

Read More

Announcing CLEAR’s 2025 Operating Grant Recipient

Announcing CLEAR Foundation’s 2025 Operating Grant Recipient, Dr. Ann Marie Craig December 17, 2025   Funding the next step forward in dementia research CLEAR Foundation is honoured to announce Dr. Ann Marie Craig, Professor of Psychiatry at UBC’s Djavad Mowafaghian Centre for Brain Health, as our 2025 Operating Grant Recipient. Dr. Craig’s research project entitled,…

Read More

Announcing The Cowell Foundation’s Major Gift to Accelerate Critical Dementia Research in British Columbia

Announcing The Cowell Foundation’s Major Gift to Accelerate Critical Dementia Research in British Columbia December 3, 2025   The Cowell Foundation empowers BC scientists with long-term funding to drive breakthroughs in dementia research. CLEAR is honoured to announce a landmark $500,000 investment from The Cowell Foundation, that will advance groundbreaking biomedical research and help shape…

Read More

November 2025 Webinar

Dementia Webinar: Beyond Plaques and Tangles – Redefining the Future of Alzheimer’s Research. November 17, 2025   Play Video Watch the Webinar Now Webinar Recap: Redefining the Future of Alzheimer’s Research  On November 17th, CLEAR Foundation supporters attended the latest instalment of our webinar series, “Making Alzheimer’s Research CLEAR”. The virtual event featured guest speaker Dr.…

Read More

Announcing CLEAR Foundation’s 2025 Year-End Match Campaign

Two people holding hands

Announcing CLEAR Foundation’s 2025 Year-End Match Campaign November 4, 2025   Your year-end gift will make DOUBLE the impact thanks to The Hastings Family CLEAR Foundation is pleased to announce the launch of our 2025 year-end fundraising campaign, with the Hastings Family generously serving as our Match Partner to advance progress toward a future without…

Read More

How virtual reality is changing the game for Alzheimer’s disease

VR technical equipment

How virtual reality is transforming Alzheimer’s disease research  Via The Cognitive Neuroscience Society October 30, 2025 How virtual reality is changing the game for Alzheimer’s disease For most people, putting on virtual reality (VR) goggles means entering a video game. But for Dr. Manu Madhav, a CLEAR-funded neuroscientist at the University of British Columbia, it’s…

Read More

Health Canada approves LEQEMBI™ the first Alzheimer’s treatment to target the underlying cause of the disease

Elderly man holding pills

Health Canada announces approveal of Alzheimer’s drug treatment LEQEMBI™  Via Biogen Canada October 27, 2025   A new era of hope for Canadians living with early Alzheimer’s disease For the first time, Canadians living with early Alzheimer’s disease have access to a treatment that targets the underlying cause of the condition. Health Canada has granted authorization with…

Read More